Advanced search
Publication Cover
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders Volume 1, 2000 - Issue 5
Journal homepage
46
Views
21
CrossRef citations to date
0
Altmetric
Research Article

Cyclin-dependent kinase-5 (CDK5) and amyotrophic lateral sclerosis

NPS Bajaj Department of Neurosciences and Clinical Neuroscience Institute of Psychiatry London SE5 8AF
Pages 319-327 | Published online: 10 Jul 2009

  • Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn Superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993; 362: 59-62.
  • McCord JM, Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 1969; 244: 6049-6055.
  • Figlewicz DA, Krizus A, Martinoli MC. Variants of the human neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum MoI Genet 1994; 3: 1757-1761.
  • Rooke K, Figlewicz DA, Han F, Rouleau CA. Analysis of the KSP repeat of the neurofilament heavy subunit in familial amyotrophic lateral sclerosis. Ann Neurol 1996; 46: 789-790.
  • Tomkins J, Usher P, Slade JY, et al. Novel insertion in the KSP region of the neurofilament heavy gene in amyotrophic lateral sclerosis (ALS). Neuroreport 1998; 9: 3967-3970.
  • AlChalabi A, Andersen PM, Nilsson P, et al. Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis. Hum MoI Genet 1999; 8:157-164.
  • Cajal SR Embryogenesis of neurofibrils. Trab Inst Cajal Invest Biol 1903; 2: 219-225.
  • Lee MK, Cleveland DW. Neuronal intermediate filaments. AnnRevNeurosci 1996; 19:187-217.
  • Shaw C. Neurofilament proteins. In: Burgoyne, RD, editor. The Neuronal Cytoskeleton. New York: Wiley-Liss, 1991: 85-214.
  • Garden MJ, Schlaepfer WW, Lee VM-Y. The structure, biochemical properties and immunogenicity of neurofilament peripheral regions are determined by phosphorylation state. J Biol Chem 1985; 260: 9805-9817.
  • Lee VM-Y, Otvos L, Garden MJ, Hollosi M, Dietzschold B, Lazzarini RA. Identification of the major multiphosphorylation site in mammalian neurofilaments. Proc Natl Acad Sd USA 1988; 85: 1998-2002.
  • Elhanany E, Jaffe H, Link WT, Sheeley DM, Gainer H, Pant HC. Identification of endogenously phosphorylated KSP sites in the high-molecular weight rat neurofilament protein. J Neurochem 1994; 63: 2324-2335.
  • Pant HC, Veeranna, Arwin ND. Neurofilament phosphorylation. Biochem Cell Biol 1995; 73: 575-592.
  • Skalli O, Chou Y-H, Goldman RD. Intermediate filaments: not so tough after all. Trends Cell Biol 1992; 2: 308-312.
  • Guan RJ, Khatra BS, Cohlberg JA. Phosphorylation of bovine neurofilament proteins by protein kinase FA (glyoogen synthase kinase-3). J Biol Chem 1991; 266: 8262-8267.
  • Guidato S, Tsai LH, Woodgett J, Miller CCJ. Differential cellular phosphorylation of neurofilament heavy side-arms by glycogen synthase kinase-3 and cylin dependent kinase-5. J Neurochem 1996; 66:1698-1706.
  • Hisinaga S, Kusubata M, Okumura E, Kishimoto T. Phosphorylation of neurofilament H subunit at the tail domain by cdc2 kinase dissociates the association to microtubules. J Biol Chem 1991; 266: 21798-21803.
  • Hisinaga S, Ishiguro K, Uchida T, Okamura E, Okano T, Kishimoto T. Tau protein kinase II has a similar characteristic to cdc2 kinase for phosphorylating neurofilament proteins. J Biol Chem 1993; 268: 15056-15060.
  • Lew J, Winkfein RJ, Paudel HE, Wang JH. Brain prolinedirected kinase is a neurofilament kinase, which displays high sequence homology to p34cdc2. J Biol Chem 1992; 267: 25922-25926.
  • Shetty KT, Link WT, Pant HC. Cdc2-like kinase from rat spinal cord specifically phosphorylates KSPXK motifs in neurofilament proteins: isolation and characterisation. Proc Nad Acad Sd USA 1993; 90: 6844-6848.
  • Miyasaka H, Okabe S, Ishiguro K, Uchida T, Hirokawa N. Interaction of the tail domain of high molecular weight subunits of neurofilaments with the COOH-terminal region of tubulin and its regulation by tau protein kinase II. J Biol Chem 1993; 268: 22695-22702.
  • Guidato S, Bajaj NPS, Miller CCJ. Cellular phosphorylation of neurofilament heavy-chain by cydin dependent kinase-5 masks the epitope for monoclonal antibody N52. Neurosci Lett 1996; 217: 157-160.
  • Sun D, Leung CL, Liem RKH. Phosphorylation of the high molecular weight neurofilament protein (NF-H) by CDK5 and p35. J Biol Chem 1996; 271: 14245-14251.
  • Bajaj NPS, Miller CCJ. Phosphorylation of neurofilament heavy-chain side-arm fragments by cyclin dependent kinase-5 and glycogen synthase-3a in transfected cells. J Neurochem 1997; 69: 737-743.
  • Veeranna, Arwin ND, Amin ND, Ahn NC, et al. Mitogenactivated protein kinases (Erkl,2) phosphorylate lys-ser-pro (KSP) repeats in neurofilament proteins NF-H and NF-M. J Neurosci 1998; 18: 4008-4021.
  • Giasson BI, Mushynski WE. Aberrant stress-induced phosphorylation of perikaryal neurofilaments. J Cell Biol 1996; 271: 30404-30409.
  • Giasson BI, Mushynski WE. Study of praline directed protein kinases involved in phosphorylation of the heavy neurofilament subunit J Neurosci 1997; 17: 9466-9472.
  • Pines J. Cydins and cyclin dependent kinases: a biochemical view. Biochem J 1995; 308: 697-711.
  • Pines J. Cyclins and cyclin dependent kinases: themes and variations. Adv Cancer Res 1995; 66: 181-212.
  • Heitz F, Morris MC, Fesquet D, Cavadore J-C, Doree M, Divita C. Interactions of the cyclins and with cyclin dependent kinases: a common interactive mechanism. Biochemistry 1997; 36: 4995-5003.
  • Lees R Cyclin dependent kinase regulation. Curr Opin Cell Biol 1995; 7: 773-780.
  • Xu Z-S, Liu WS, Willard M. Identification of six phosphoryiation sites in the COOH-terminal tail region of the rat neurofilament protein-M. J Biol Chem 1992; 267: 4467-4471.
  • Meyerson M, Enders GH, Wu C-L, et al. A family of cdc2related protein kinases. EMBO J 1992; 11: 2909-2917.
  • Lew J, Baudette, K, Litwin CME, Wang JH. Purification and characterisation of a novel proline-directed kinase from bovine brain. J Biol Chem 1992; 267: 13383-13390.
  • Hellmich MR, Pant HC, Wada E, Battey JF. Neuronal cdc2like kinase: a cdc2-related protein kinase with predominately neuronal expression. Proc Natl Acad Sd USA 1992; 89: 10867-10871.
  • Tsai L-H, Takahashi T, Caviness VS, Harlow R Activity and expression pattern of cyclin dependent kinase-5 in the embryonic mouse nervous system. Development 1993; 119: 1029-1040.
  • Xiong Y, Zhang H, Beach D. D-type cyclins associate with multiple protein-kinases and the DNA-replication and repair factor PCNA. CelI 1992; 71: 505-514.
  • Lew J, Huang QQ, Qi Z, et al. A brain-specific activator of cyclin dependent kinase-5. Nature 1994; 371: 423-426.
  • Tsai L-H, Delalle I, Caviness VS, Chae T, Harlow R p35 is a neural specific regulatory subunit of CDK5. Nature 1994; 371: 419-423.
  • Lew J, Wang JH. Neuronal cdc2-like kinase. Trends Biochem Sd 1995; 20: 33-37.
  • Poon RYC, Lew J, Hunter T. Identification of functional domains in the neuronal CDK5 activator protein. J Biol Chem 1997; 272: 5703-5708.
  • Patrick GN, Zhou P, Kwon YT, Howley PM, Tsai L-H. p35, the neuronal-spedfic activator of cyclin dependent kinase-5 (CDK5) is degraded by the ubiquitin-proteosome pathway. J Biol Chem 1998; 273: 24057-24064.
  • van der Heuvel S, Harlow R Distinct role for cyclin dependent kinases in cell cycle control. Science 1993; 262: 2050-2054.
  • Matsuura I, Wang JH. Demonstration of cyclin dependent kinase inhibitory serine/threonine kinase in bovine thymus. J Biol Chem 1996; 271: 5443-5450.
  • Lee K-Y, Rosales JL, Tang D, Wang JH. Interaction of cyclin dependent kinase-5 (CDKS) and neuronal CDK5 activator in bovine brain. J Biol Chem 1996; 271: 1538-1543.
  • Moorthamer M, Chaudhuri B. Identification of a ribosomal protein L34 as a novel CDK5 inhibitor. Biochem Biophys Res Comm 1999; 255: 631-638.
  • Moorthamer M, Zumstein-Mecker S, Chaudhuri B. DNA binding protein dbpA binds CDK5 and inhibits its activity. FEBS Lett 1999: 446: 343-350.
  • Zheng M, Leung CL, Iiem RKH. Region-specific expression of cyclin dependent kinase-5 (CDK5) and its activators, p35 and p39, in the developing and adult rat central nervous system. J Neurobiol 1998; 35:141-159.
  • Ino H, Ishizuka T, Chiba T, Tatibana M. Expression of CDK5 (PSSALRE kinase), a neural cdc2-related proteinkinase, in the mature and developing mouse central and peripheral nervous systems. Brain Res 1994; 661: 196-206.
  • Matsushita M, Tomizawa K, Lu YFM, et al. Distinct cellular compartment of cyclin dependent kinase-5 (CDK5) and neurone-specific CDK5 activator protein (p35[nCK5a]) in the developing rat cerebellum. Brain Res 1996; 734: 319-322.
  • Nikolic M, Dudek H, Kwon YT, Ramos YFM, Tsai L·H. The CDK5/p35 kinase is essential for neunte outgrowth during neuronal differentiation. Genes Devel 1996; 10: 816-825.
  • Hall A. Rho GTPases and the actin cytoskeleton. Science 1998; 279: 509-514.
  • Nikolic M, Chou MM, Lu W, Mayer BJ, Tsai L·H. The CDK5/p35 kinase is a neurone specific Rac effector that inhibits Pakl activity. Nature 1998; 395: 194-198.
  • Ohshima T, Ward JM, Huh CC, et al. Targeted disruption of the cyclin dependent kinase-5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc Natl Acad Sd USA 1996; 93: 11173-11178.
  • Chae T, Kwon YT, Bronson R, Dikkes P, Li E, Tsai L-H. Mice lacking p35, a neuronal specific activator of CDK5, display cortical lamination defects, seizures, and adult lethality. Neuron 1997; 18: 29-42.
  • Philpott A, Porro EB, Kirschner MW, Tsai L-H. The role of cyclin dependent kinase-5 and a novel regulatory subunit in regulating muscle differentiation and patterning. Genes Devel 1997; 11: 1409-1421.
  • Ratner N, Bloom GS, Brady S. A role for cyclin dependent kinase(s) in the modulation of fast anterograde axonal transport effects defined by olomudne and the APC tumour suppresser protein. J Neurosci 1998; 18: 7717-7726.
  • Sudhof TC. The synaptic vesicle cycle: a cascade of proteinprotein interactions. Nature 1995; 375: 645-653.
  • Hanson PI, Heuser JE, Jahn R. Neurotransmitter release four years of SNARE complexes. Curr Opinion Neurobiol 1997; 7: 310-315.
  • Shuang R, Zhang L, Fletcher A, Groblewski GE, Pevsner J, Stuenkel EL. Regulation of munc-18/syntaxin IA interaction by cyclin dependent kinase-5 in nerve endings. J Biol Chem 1998; 273: 4957-4966.
  • Fletcher AI, Shuang R, Giovannucci DR, Zhang L, Bittner MA, Stuenkel EL. Regulation of exocytosis by cyclin dependent kinase-5 via phosphorylation of munc18. J Cell Biol 1999; 274: 4027-4035.
  • Lee K-Y, Qi Z, Yu YP, Wang JH. Neuronal cdc-2 like kinases: neurone-specific forms of CDK5. Int J Biochem Cell Biol 1997; 29: 951-958.
  • Goedert M, Crowther RA, Garner CC. Molecular characteri-sation of microtubule-assodated proteins tau and MAP2. Trends Neurosci 1991; 14: 193-199.
  • Goedert M. Tau protein and the neurofibrillary pathology of Alzheimer's disease. Trends Neurosci 1993; 16: 460-465.
  • Kobayashi S, Ishiguro K, Omori A, et al. A cdc2-related kinase PSSALRE/CDK5 is homologous with the 30 kDa subunit of tau protein kinase II, a proline-directed protein kinase associated with microtubules. FEBS Lett 1993; 335: 171-175.
  • Paudel HK, Lew J, AIi Z, Wang JH. Brain proline directed protein kinase phosphorylates tau on sites that are abnormally phosphorylated in tau associated with Alzheimer's paired helical filaments. J Biol Chem 1993; 31: 23512-23518.
  • Morishima-Kawashima M, Hasegawa M, Takio K, et al. Proline directed and non-proline directed phosphorylation of PHF-tau. J Biol Chem 1995; 270: 823-829.
  • Michel G, Mercken M, Murayama M, et al. Characterisation of tau phosphorylation in glycogen synthase kinase-3ß and cyclin dependent kinase-5 activator (p23) transfected cells. Biochim Biophys Acta - Molec Basis Dis 1998; 1380: 177-182.
  • Patrick CN, Zukerberg L, Nikolic M, de la Monte S, Dikkes P, Tsai L-H. Conversion of p35 to p25 deregulates CDK5 activity and promotes neurodegeneration. Nature 1999; 402: 615-622.
  • Leigh PN, Dodson A, Swash M, Brion J-P, Anderton B. Cytoskeletal abnormalities in motor neurone disease. Brain 1989; 112: 521-535.
  • Hirano A. Cytopathology of amyotrophic lateral sclerosis. In: Rowlan LP, editor. Advances in Neurology: Amyotrophic lateral sclerosis and other motor neurone diseases. New York Raven Press, 1991: 91-101.
  • Xu Z, Cork LC, Griffin JW, Cleveland DW. Involvement of neurofilaments in motor neurone disease. J Cell Sei 1993; 17: 101-108.
  • Wong PC, Pardo CA, Borchelt DR, et al. An adverse property of a familial ALS-linked SODl mutation causes motorneuron disease characterised by vacuolar degeneration of mitochondria. Neuron 1995; 14:1105-1116.
  • Reaume AC, Elliott JL, Hoffman EK, et al. Motor neurones in Cu/Zn Superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nature Genet 1996; 13: 43-47.
  • Cote F, Collard JF, Julien JP. Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: a mouse model of amyotrophic lateral sclerosis. Cell 1993; 73: 35-46.
  • Xu Z, Cork LC, Griffin JW, Cleveland DW. Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neurone disease. Cell 1993; 73: 23-33.
  • Lee MK, Marszalek JR, Cleveland DW. A mutant neurofilament subunit causes massive, selective motor neurone death: implications for the pathogenesis of human motor neurone disease. Neuron 1994; 13: 975-988.
  • Tu PH, Raju P, Robinson KA, Gurney ME, Trojanowski JQ, Lee VM-Y. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. Proc Natl Acad Sd USA 1996; 93: 3155-3160.
  • Williamson TL, Bruijn LI, Zhu Q, et al. Absence of neurofilaments reduces the selective vulnerability of motor neurones and slows disease caused by familial amyotrophic lateral sclerosis-linked Superoxide dismutase 1 mutant Proc Natl Acad USA 1998; 95: 9631-9636.
  • Couillard-Despres S, Zhu Q, Wong PC, Price DL, Cleveland DW, Julien J-P. Protective effect of neurofilament heavy gene over-expression in motor neurone disease induced by mutant Superoxide dismutase. Proc Natl Acad USA 1998; 95: 9626-9630.
  • Williamson TL, Cleveland DW. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SODl mutants to motor neurones. Nature Neurosci 1999; 2:50-56.
  • Hirokawa N. The crosslinker system between neurofilaments, microtubules and membranous organelles revealed by quick freeze, freeze fracture, deep-etching method. J Cell Biol 1982; 94: 129-142.
  • Hirokawa N, Glicksman MA, Willard MB. Organisation of mammalian neurofilament polypeptides within the neuronal cytoskeleton. J Cell Biol 1984; 98: 1523-1536.
  • Julien JP, Cote F, Beaudet L, Sidky M, Flavell D. Sequence and structure of the mouse gene coding for the largest neurofilament subunit Gene 1988; 68: 307-314.
  • Beaudette KN, Lew J, Wang JH. Substrate specificity characterisation of a cdc2-like protein kinase purified from bovine brain. J Biol Chem 1993; 268: 20825-20830.
  • Brion JP, Couck AM. Cortical and brain stem-type Lewy bodies are immunoreactive for cyclin dependent kinase-5. AmJPathol 1995; 147: 1465-1476.
  • Yamaguchi H, Ishiguro K, Uchida T, Takashima A, Lemere CA, Imahori K. Preferential labelling of Alzheimer neurofibrillary tangles with antisera for tau-protein kinase (TPK-I) (glycogen-synthase kinase-3ß) and cyclin dependent kinase-5, a component of TPK-II. Acta Neuropathol 1996; 92: 232-241.
  • Nakamura S, Kawamoto Y, Nakano S, Akiguchi I, Kimura J. p35(nck5a) and cyclin dependent kinase-5 co-localise in Lewy bodies of brains with Parkinson's disease. Acta Neuropathol 1997; 94: 153-157.
  • Pei J-J, Grundke-Iqbal I, Iqbal K, Bogdanovic N, Winblad B, Cowburn RF. Accumulation of cyclin dependent kinase-5 (CDKS) in neurones with early stages of Alzheimer's disease neurofibrillary degeneration. Brain Res 1998; 797: 267-277.
  • Nakamura S, Kawamoto Y, Nakano S, Ikemoto A, Akiguchi I, Kimura J. Cyclin dependent kinase-5 in Lewy body-like inclusions in anterior horn cells of a patient with sporadic amyotrophic lateral sclerosis. Neurology 1997; 48: 267-270.
  • Bajaj NPS, Al-Sarraj S, Kibble M, Anderson V, Leigh PN, Miller CCJ. CDKS associates with lipofuscin in motor neurones in ALS. Neurosci Lett 1998; 217: 1-4.
  • Bajaj NPS, Al-Sarraj ST, Leigh PN, Anderson V, Miller CCJ. Cyclin dependent kinase-5 (CDKS) phosphorylates neurofilament heavy (NF-H) chain to generate epitopes for antibodies that label neurofilament accumulations in amyotrophic lateral sclerosis (ALS) and is present in affected motor neurones in ALS. Progr Neuro-psychopharmacol Biol Psychiatry 1999; 23: 833-850.
  • Brunk UT, Jone CB, Sohal RS. A novel hypothesis of lipofuscinogenesis and cellular ageing based upon interactions between oxidative stress and autophagocytosis. Mutat Res 1992; 275: 395-403.
  • Tu PH, Gurney ME, Julien J-P, Lee VM-Y, Trojanowski JQ. Oxidative stress, mutant SODl and neurofilament pathology in transgenic mouse models of human motor neurone disease. Lab Invest 1997; 76: 441-456.
  • Greenland LJS, Deckwerth II, Johnson EM. Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death. Neuron 1995; 14: 303-315.
  • Rabizadeh S, Gralla EB, Borchelt DR, et al. Mutations associated with amyotrophic lateral sclerosis convert Superoxide dismutase from an anti-apoptotic gene to a pro-apoptotic gene: studies in yeast and neural cells. Proc Natl Acad Sd USA 1995; 92: 3024-3028.
  • Mu X, He J, Anderson DW, Trojanowski JQ, Springer JE Altered expression of bcl-2 and bax mRNA in amyotrophic lateral sclerosis spinal cord motor neurones. Ann Neurol 1996; 40: 379-386.
  • Migheli A, Cavalla P, Piva R, Giordana MT, Schiffer D. bcl-2 protein expression in aged brain and neurodegenerative disease. Neuroreport 1994; 5: 1906-1908.
  • Meikrantz W, Schlegel R. Suppression of apoptosis by dominant-negative mutants of cyclin dependent protein kinases. J Biol Chem 1996; 271: 10205-10209.
  • Ahuja HS, Zhu Y, Zakeri Z. Association of cyclin dependent kinase-5 and its activator p35 with apoptotic cell death. Dev Genet 1997; 21: 258-267.
  • Zhang Q, Ahuja HS, Zakeri ZF, Wolgemuth DJ. Cyclin dependent kinase-5 is associated with apoptotic cell death during development and tissue remodelling. Dev Biol 1997; 183: 222-233.
  • Shirvan A, Ziv I, Zilkha-Falb R, Machlyn T, Barzilai A, Melamed E. Expression of cell cycle-related genes during neuronal apoptosis: is there a distinct pattern? Neurochem Res 1998; 23: 767-777.
  • Bajaj NPS, Leigh PN, Miller CCJ. CDK5 induces apoptosis in cultured mammalian cells and accumulates in lipofuscin in ALS (abstract). J Neural 1998; 245: 347.
  • Lee K-Y, Helbing CC, Choi K-S, Johnston RN, Wang J. Neuronal cdc2-like kinase (Ndk) binds and phosphorylates the retinoblastoma protein. J Biol Chem 1997; 272: 5622-5626.
  • Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 1995; 81: 323-330.
  • Ross ME Cell division and the nervous system: regulating the cell cycle from neural differentiation to death. Trends Neurosci 1996; 19: 62-68.
  • Herwig S, Strauss M. The retinoblastoma protein: a master regulator of the cell cycle, differentiation and apoptosis. Eur J Biochem 1997; 246: 581-601.
  • Brehm A, Miska EA, McCance DJ, Rad JL, Bannister AJ, Kouzarides T. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 1998; 391: 597-601.
  • Magnaghi Jaulin L, Groisman R, Naguibneva I, et al. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 1998; 391: 601-605.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.